artificial sweetener aspartame subject several controversies since initial approval us food drug administration fda fda approval aspartame highly contested beginning suspicions involvement brain alleging quality initial research supporting safety inadequate flawed conflicts interest marred approval aspartame previously evaluated two fda panels concluded keep approval hold us government accountability office concluded food additive approval process followed properly irregularities fueled conspiracy theory nancy markle email hoax circulated along weight medical numerous health conditions multiple sclerosis systemic lupus methanol toxicity blindness spasms shooting pains seizures headaches depression anxiety memory loss birth defects caused consumption aspartame normal aspartame methyl ester aspartic acidphenylalanine dipeptide potential health risks examined dismissed numerous scientific research projects exception risk phenylketonuria aspartame considered safe food additive governments worldwide major health food safety fda officials describe aspartame one thoroughly tested studied food additives agency ever approved safety clear weight existing scientific evidence indicates aspartame safe nonnutritive controversy aspartame safety originated perceived irregularities aspartame approval process early including allegations revolving door relationship regulators industry claims aspartame producer gd searle withheld falsified safety data controversy reached wider audience minutes discussed criticisms fda approval process concerns aspartame could cause brain tumors humans minutes special stated aspartames approval one contested fda around time usenet post widely circulated pen name nancy markle creating basis misleading unverifiable hoax chain letter spread numerous websites spread emails claims supported scientific evidence safety issues purportedly linked aspartame including gulf war syndrome aspartame originally approved use dry foods fda commissioner alexander schmidt review fdas center food safety applied nutrition searle submitted aspartame including seven animal studies considered crucial soon afterwards john olney professor psychiatry prominent critic msg along james turner publicinterest lawyer author antifoodadditive book filed petition public hearing citing safety criticisms presented minutes special searle studies included assertions unreported medical treatments may affected study outcomes discrepancies reported schmidt agreed pending investigation alleged improprieties safety studies aspartame several drugs december fda placed stay aspartame approval preventing searle marketing searle studies criticized fda commissioner best sloppy suffering pattern conduct compromises scientific integrity us attorney samuel skinner requested open grand jury investigation whether two searles aspartame studies falsified skinner withdrew case considering job offer law firm sidley austin searles chicagobased law firm job later investigation delayed eventually statute limitations charges searle grand jury never fda task force panel academic pathologists reviewed aspartame studies searle concluded although major lapses quality control resulting inconsistencies would affected studies public board inquiry pboi heard testimony olney disagreed claims aspartame could cause brain damage including developing board decided study needed postulated connection aspartame brain tumors revoked approval fda commissioner arthur hull hayes sought advice issue panel fda scientists lawyer panel identified errors underlying pboi conclusion aspartame might cause brain tumors presented arguments hayes approved use aspartame dry foods hayes justified approval citing results japanese brain tumor results pboi chairman later said would resulted unqualified approval pboi several objections followed november year approving aspartame hayes left fda joined publicrelations firm bursonmarsteller searles public relations agency time senior medical actions samuel skinner taking job law firm retained searle investigation searle arthur hull hayes taking job searles public relations agency following aspartames approval fueled conspiracy approval controversy senator howard metzenbaum requested investigation us government accountability office gao aspartames approval gao reported protocol followed provided timeline events approval gao review included survey scientists conducted safety reviews scientists responded questionnaire major concerns aspartames safety somewhat concerned generally confident aspartame safety confident aspartame food additive safety evaluations many countries led approval aspartame citing general lack adverse effects following consumption reasonable based government research reviews recommendations advisory bodies listed aspartame found safe human consumption ninety countries fda notified thenus attorney chicago sam skinner ongoing investigation searle january formally requested grand jury convened february searles law firm sidley austin offered skinner job skinner recused mr skinners successor place several months later statute limitations alleged offenses expired october despite complaints urging doj washington neither interim us attorney chicago william conlon skinners successor thomas sullivan convened grand december sullivan ordered case dropped lack evidence year half later conlon also hired sidley concern conflict interest case inflamed controversy senator metzenbaum investigated senate us senate approved nomination sam skinner secretary transportation noting sullivan senator metzenbaum concluded skinner acted ralph g walton psychiatrist northeastern ohio universities college medicine stated selfpublished analysis aspartame research industryfunded studies found safety concerns independent studies identify safety analysis walton submitted television show minutes extensively discussed internet analysis waltons claims showed walton left least peerreviewed safety studies review literature research cites nonindustry funded actually letters editors case reports review articles book chapters rather published rebuttal waltons statements aspartame information service service provided ajinomoto primary producer supplier aspartame reviewed publications walton cites critical aspartame arguing involve aspartame draw negative conclusions peerreviewed anecdotal elaborate health involving hoax conspiracy theory disseminated many websites attributes host deleterious medical effects aspartame theory claims fda approval process aspartame cites source email based upon supposed talk nancy markle thought betty martini first circulated world environmental specifically hoax websites allege aspartame responsible multiple sclerosis systemic lupus methanol toxicity causing blindness spasms shooting pains seizures headaches depression anxiety memory loss birth defects proliferation websites many sensationalist urls filled anecdotal claims medical markle hoax extended argument aspartamekillscom supported medical email described internet smear campaign contents entirely false misleading defamatory various popular products manufacturers basis whatever markle email says conspiracy fda producers aspartame conspiracy theory become canonical example discussed several internet conspiracy theory urban legend although allegations theory contradict bulk medical misinformation spread around world chain emails since middecember influencing many urban legend continues scare media awareness network featured one version tutorial determine credibility web page tutorial implied markle letter credible stated used authoritative source dean edell warned strongly markle letter due public concerns uk government introduced new regulation obliging food makers use sweeteners state clearly next name product phrase indonesian government considered banning philippines small political party alliance rural concerns introduced house bill aim aspartame banned food us state new mexico bill ban aspartame introduced subsequently similar hawaii bill stalled committee lack march california oehha identified aspartame chemical consultation carcinogen identification committee accordance california state proposition reviewed november uk supermarket chains sainsburys marks walmart subsidiary asda announced would longer use aspartame label products april ajinomoto sweeteners europe one makers aspartame europe responded asdas nasties campaign filing complaint malicious falsehood asda english july asda initially legal case trial judge construed nasties labelling mean aspartame potentially harmful decision reversed june upon settled asda removing references aspartame south african retailer woolworths announced removing aspartamecontaining foods ownbrand british food standards agency funded clinical study people claimed experience sideeffects consuming double blind controlled study concluded found evidence safety issues side effects even amongst volunteers previously claimed sensitivity fsas committee toxicity evaluated results meeting october determined results presented indicate need action protect health european food safety authority efsa commenced reevaluation aspartame part systematic reevaluation food additives authorized eu prior january may efsa asked european commission bring forward full reevaluation safety aspartame e previously planned completion september efsa made datasets using full reevaluation available publicly includes previously unpublished scientific data including original studies aspartame submitted support request authorization aspartame europe early january efsa released draft report found aspartame metabolites pose toxicity concern consumers current levels exposure current acceptable daily intake adi considered safe general population consumer exposure aspartame cesare maltoni cancer research center european ramazzini foundation oncology environmental sciences erf published studies claiming aspartame increases several malignancies rodents concluding potential carcinogen normal dietary open letter center science public interest cspi fda endorsed thirteen occupational safety health experts expressed erf studies merited reevaluation aspartames safety reviewing foundations claims discounted study results finding significant methodological issues reason retain previously established acceptable daily intake levels aspartame incomplete release data including pathology slides erf restricted efsa based upon data provided erfs published conclusions supportable regulatory agencies health british committee carcinogenicity chemicals food consumer products likewise found methodological problems research justified rejecting claims retaining established policy contemporaneous fda esfa reviews ajinomoto company developer review safety regulatory consulting firm burdock group blind safety review tenmember international panel experts magnuson scientific literature concurred regulatory agency evaluations finding many flaws studys design implementation included unspecified composition corticella diet method adding aspartame leading possible nutritional deficiencies contamination issue unspecified aspartame storage conditions handling ignoring several industry animal randomization use institutes randomly bred lines remained pathogen carriers opposed readily available pathogenfree animals use fulllife animals resulting age variation death comparing animals younger controls highdensity housing housing different animal groups different conditions unusually high incidence confounding infections known cause lymphoid neoplasmas lesions earlier greater rates test species pooling tumors lymphomas leukemias different tissue types despite standing research induced tumors differentiated naturally occurring insufficientincompleteconflicting methodology data collectionreporting multiple areas us national toxicology programs finding erf misdiagnosed hyperplasias malignancies finding comprehensive contradiction research literature reasonable danger combination erfs design implementation issues magnuson concluded research constitute credible evidence carcinogenicity aspartame another review criticized erf relying science press conference release results media published proper peerreviewed journal thus helping fuel controversy publicity study efsa evaluated studies published erf finding continued multiple significant design flaws prohibiting interpretation insufficient influence reconsideration aspartame july scientists international agency research cancer iarc world health organization concluded limited evidence aspartame causing cancer humans classifying sweetener possibly joint faowho expert committee food additives jecfa stated limited cancer assessment confirmed reason change recommended acceptable daily intake level mg per kg body weight per day reaffirming safety consuming aspartame within us food drug administration fda responded report stating aspartame labeled iarc possibly carcinogenic humans mean aspartame actually linked cancer fda disagrees iarcs conclusion studies support classifying aspartame possible carcinogen humans fda scientists reviewed scientific information included iarcs review first made available identified significant shortcomings studies iarc httpsenwikipediaorgwikiaspartamecontroversy